Methotrexate suppresses psoriatic skin inflammation by inhibiting muropeptide transporter SLC46A2 activity
Authors:
Open Access
- 27 April 2023
- Vol. 56 (5) , 998-1012.e8
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Kenneth Rainin Foundation
- National Institutes of Health
- National Cancer Institute (K22CA262355)
- National Institute of General Medical Sciences (5T32GM133395, R01GM138599)
- National Institute of Allergy and Infectious Diseases (R00AI130258, ROAI060025)
- Richard and Susan Smith Family Foundation
- Pew Charitable Trusts
This publication has 74 references indexed in Scilit:
- Cytosolic surveillance and antiviral immunityCurrent Opinion in Virology, 2011
- The Solute Carrier Family 15A4 Regulates TLR9 and NOD1 Functions in the Innate Immune System and Promotes Colitis in MiceGastroenterology, 2011
- Identification of Drosophila Yin and PEPT2 as Evolutionarily Conserved Phagosome-associated Muramyl Dipeptide TransportersJournal of Biological Chemistry, 2010
- The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA virusesNature Immunology, 2010
- pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 SignalingJournal of Biological Chemistry, 2009
- Functional Expression of the Intracellular Pattern Recognition Receptor NOD1 in Human KeratinocytesJournal of Investigative Dermatology, 2009
- Substantial Alterations of the Cutaneous Bacterial Biota in Psoriatic LesionsPLOS ONE, 2008
- Activation of NOD2 in vivo induces IL-1β production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signalingJournal of Leukocyte Biology, 2008
- Expression analysis of G Protein-Coupled Receptors in mouse macrophagesImmunome Research, 2008
- hPepT1 selectively transports muramyl dipeptide but not Nod1-activating muramyl peptidesCanadian Journal of Physiology and Pharmacology, 2006